Epinex Diagnostics is a medical device company that specializes in the development of innovative rapid tests that target major deficiencies in existing healthcare markets. Our proprietary platform for rapid tests uses existing technologies to create unique quantitative diagnostic tests for the point-of-care (POC) and over-the-counter (OTC) markets. The Company’s flagship product is the G1A™ Rapid Diabetes Monitoring Index Test, a patented monthly test for diabetes monitoring.  The Test has the potential to improve diabetes care and have a successful impact on the current worldwide diabetes epidemic, the most significant chronic disease affecting the world today.

Epinex Diagnostics, Inc. is located in Tustin, California, adjacent to the University of California, Irvine, in the heart of the Southern California biomedical industry.